TNF and metabolic dysfunction-associated steatotic liver disease: More studies evaluating the role and utility of circulating, hepatic, and tumor TNF-α, specifically in patients with NAFLD-associated HCC, are warranted in the future to better define the association between circulating TNF-α with hepatic TNF-α from both malignant and healthy hepatic tissues.